Methotrexate 0.5 mg/kg to 10 mg/kg (0, 24, 48 hour of antigen exposure) and continue antigen exposure weekly or on a biweekly basis. If you have a control group (antigen only) set up along with your immunomodulator group, you will see the difference in antibodies seen against your antigen.
If you want to look at role of immunomodulation in an established immune response setting, look up for bortezomib. Bortezomib is a proteasome inhibitor and targets mature antibody producing plasma cells (which is the final source of antibody production). For this experiment, you can provoke antibodies against your desired antigen and then administer bortezomib (0.75 mg/kg on day 1, 4, 8 and 11) and you will see a drop in antibody titers. you can repeat bortezomib administration to see the further drop in antibodies
Other agents: Rituximab (its a human antiCD20 so you need to find mice specific antiCD20) it targets B cells
Rapamycin as others have mentioned is another agent. Also mycophenolate moefetil, azathioprine, cyclosporine